P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY

Bibliographic Details
Main Authors: Curtis Lachowiez, Christina Zettler, Anna Barcellos, Andrew Belli, Laura Fernandes, Eric Hansen, Ching-Kun Wang, Ronan Swords
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000968964.32175.7d
_version_ 1827332518667354112
author Curtis Lachowiez
Christina Zettler
Anna Barcellos
Andrew Belli
Laura Fernandes
Eric Hansen
Ching-Kun Wang
Ronan Swords
author_facet Curtis Lachowiez
Christina Zettler
Anna Barcellos
Andrew Belli
Laura Fernandes
Eric Hansen
Ching-Kun Wang
Ronan Swords
author_sort Curtis Lachowiez
collection DOAJ
first_indexed 2024-03-07T17:01:10Z
format Article
id doaj.art-9fff253f28a048dabd3fceb03ae3db9a
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:01:10Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-9fff253f28a048dabd3fceb03ae3db9a2024-03-03T03:24:19ZengWileyHemaSphere2572-92412023-08-017e321757d10.1097/01.HS9.0000968964.32175.7d202308003-00415P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPYCurtis Lachowiez0Christina Zettler1Anna Barcellos2Andrew Belli3Laura Fernandes4Eric Hansen5Ching-Kun Wang6Ronan Swords71 Oregon Health and Science University, Portland, United States2 Cota, Inc., New York, United States2 Cota, Inc., New York, United States2 Cota, Inc., New York, United States2 Cota, Inc., New York, United States2 Cota, Inc., New York, United States2 Cota, Inc., New York, United States1 Oregon Health and Science University, Portland, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000968964.32175.7d
spellingShingle Curtis Lachowiez
Christina Zettler
Anna Barcellos
Andrew Belli
Laura Fernandes
Eric Hansen
Ching-Kun Wang
Ronan Swords
P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
HemaSphere
title P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_full P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_fullStr P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_full_unstemmed P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_short P514: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES OF MOLECULAR SUBGROUPS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING FRONTLINE VENETOCLAX-BASED THERAPY
title_sort p514 treatment patterns and real world outcomes of molecular subgroups in patients with acute myeloid leukemia receiving frontline venetoclax based therapy
url http://journals.lww.com/10.1097/01.HS9.0000968964.32175.7d
work_keys_str_mv AT curtislachowiez p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT christinazettler p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT annabarcellos p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT andrewbelli p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT laurafernandes p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT erichansen p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT chingkunwang p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy
AT ronanswords p514treatmentpatternsandrealworldoutcomesofmolecularsubgroupsinpatientswithacutemyeloidleukemiareceivingfrontlinevenetoclaxbasedtherapy